Ascentage Pharma Group International Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 6855?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	38,396,433	10.4%
Individual Insiders	47,432,404	12.9%
Institutions	52,081,587	14.2%
General Public	230,149,669	62.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 36.89% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.6%	Takeda Pharmaceuticals International AG	24,307,322	HK$896.5m	0%	no data
6.32%	Dajun Yang	23,247,700	HK$857.4m	0.41%	no data
3.83%	HealthQuest Pharma Limited	14,089,111	HK$519.6m	0%	no data
3.6%	Ming Guo	13,234,026	HK$488.1m	0%	no data
2.73%	Shaomeng Wang	10,053,943	HK$370.8m	0%	no data
2.4%	Vanguard Capital Management, LLC	8,834,828	HK$325.8m	0.36%	no data
1.72%	Morgan Stanley	6,344,903	HK$234.0m	0%	no data
1.69%	JPMorgan Chase & Co.	6,205,144	HK$228.8m	0%	no data
1.45%	BlackRock, Inc.	5,348,200	HK$197.2m	-0.26%	no data
1.21%	Norges Bank Investment Management	4,459,482	HK$164.5m	0%	no data
1.07%	Yinhua Fund Management Co., Ltd.	3,949,900	HK$145.7m	0%	0.08%
0.82%	China Universal Asset Management Company Ltd.	3,009,800	HK$111.0m	0%	0.03%
0.62%	Vanguard Fiduciary Trust Company	2,278,772	HK$84.0m	0.85%	no data
0.49%	China Asset Management Co. Ltd.	1,799,530	HK$66.4m	3.3%	0.01%
0.48%	Maxwealth Fund Management Co., Ltd	1,765,000	HK$65.1m	0%	0.04%
0.43%	Bosera Asset Management Co., Ltd.	1,565,900	HK$57.8m	0%	0.03%
0.28%	E Fund Management Co., Ltd.	1,021,420	HK$37.7m	0.39%	no data
0.25%	GF Fund Management Co., Ltd.	927,900	HK$34.2m	0%	0.01%
0.23%	Fullgoal Fund Management Co. Ltd.	861,900	HK$31.8m	0%	0.01%
0.16%	Harvest Fund Management Co. Ltd.	576,200	HK$21.3m	0%	no data
0.13%	State Street Global Advisors, Inc.	488,100	HK$18.0m	2.89%	no data
0.11%	Yifan Zhai	405,280	HK$14.9m	29.7%	no data
0.098%	Thomas Knapp	362,444	HK$13.4m	0%	no data
0.097%	China Southern Asset Management Co., Ltd.	355,300	HK$13.1m	0%	no data
0.08%	First Seafront Fund Management Co., Ltd	295,000	HK$10.9m	0%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/06 09:32
End of Day Share Price	2026/07/06 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ascentage Pharma Group International is covered by 25 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yang Huang	BofA Global Research
Mayank Mamtani	B. Riley Securities, Inc.
Suranjit Mukherjee	BTIG